Redo-aortic valve replacement in prior stentless prosthetic aortic valves: Transcatheter versus surgical approach.
Charles H ChoiKevin CaoDiego MalaverEdward H KincaidAdrian LataNeal KonP Matthew BelfordSanjay K GandhiRobert J ApplegateDavid X M ZhaoPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2021)
Although the ViV-TAVR group had higher risk patients, there were significantly fewer procedural complications, shorter length of stay, and similar mortality outcomes up to 1-year follow-up.
Keyphrases
- aortic valve replacement
- aortic valve
- aortic stenosis
- ejection fraction
- transcatheter aortic valve implantation
- transcatheter aortic valve replacement
- end stage renal disease
- left ventricular
- risk factors
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- coronary artery disease
- cardiovascular events
- cardiovascular disease
- patient reported
- insulin resistance
- glycemic control
- pulmonary arterial hypertension